The United Kingdom will formally leave the European Union on 31 January 2020 and will become a third country to the EU. On 1 February 2020 a transition period will start which is due to end on 31 December 2020.
31 January, 2020
New resource that categorises genes essential for supporting life could be used to identify rare disease mutations
31 January, 2020
Researchers at the University of Dundee have developed an unrivalled, fully automated robotic screening system which allows them to rapidly test the effect of drugs and other chemicals on human sperm.
30 January, 2020
This new development from a collaborative team of international scientists shows promise for the treatment of herpes simplex (cold sore virus), respiratory syncytial virus, hepatitis C, HIV, and Zika virus to name a few. The team have demonstrated success treating a range of viruses in the lab – including respiratory infections to genital herpes.
29 January, 2020
A nasal spray for treatment-resistant depression has not been recommended by NICE because of uncertainties over its clinical and cost effectiveness.
28 January, 2020
Proposals feature a soft robotic heart, cure for genetic heart disease, heart attack vaccine and next generation health tech
23 January, 2020
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines’ effectiveness. The analysis, published by the Journal of the Royal Society of Medicine, assessed 12 published Phase 2 and 3 randomised controlled efficacy trials of the HPV vaccines Cervarix and Gardasil.
22 January, 2020
The topic of this month’s newsletter from Drug Discovery Today is “We are family”.
21 January, 2020
Next-generation gene editing system has applications in development of cell and gene therapies. Base editing builds on CRISPR offering and will expand Horizon’s research tools and services. Horizon seeks partners to assess and shape platform development
15 January, 2020
CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has partnered with imec, a world-leading research and innovation hub active in the fields of nanoelectronics and digital technologies, to increase production of Evonetix’s proprietary microelectromechanical systems (MEMS)-based silicon chips, enabling the platform to be manufactured at a commercial scale. The novel silicon chip is a key component of Evonetix’s desktop DNA platform which, once fully developed, will facilitate and enable the rapidly growing field of synthetic biology.
13 January, 2020
The participants of the EIT Health Headstart Programme will receive strong regional support and integration into the ecosystem, as well as funding to bring their innovations to the market. Headstart start-ups address disease areas and challenges from Parkinson’s to obesity, with the innovations spanning the categories of medtech, digital health and biotech.
13 January, 2020
Joint Venture to develop next generation cell and gene therapies incorporating Affimer proteins
13 January, 2020
Researchers at the University of Dundee are aiming to make a breakthrough against tuberculosis.
13 January, 2020
Collaboration of researchers will improve imaging methods to assess extent of drug delivery to the skin – including creams and lotions for conditions like eczema
10 January, 2020
Web-based platform provides broad access to the first-ever cloud laboratory to integrate automated biology and chemistry research capabilities in a closed-loop system that enables an accelerated design-make-test-analyze cycle
10 January, 2020
“TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis” published in American Journal of Respiratory and Critical Care Medicine. The paper, Co-authored by researchers from University of Sussex, University of North Carolina and University of Miami, demonstrates first in class TMEM16A chloride channel potentiators, to accelerate mucociliary clearance
10 January, 2020
PhoreMost to deploy its SITESEEKER platform to identify novel targets for Boehringer Ingelheim’s discovery programmes
08 January, 2020
Researchers at the University of East Anglia are crowd-funding a new project to test former professional football players for early signs of dementia.
07 January, 2020